640 related articles for article (PubMed ID: 16920750)
1. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
2. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
3. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
4. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
7. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
9. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.
Puissant B; Barreau C; Bourin P; Clavel C; Corre J; Bousquet C; Taureau C; Cousin B; Abbal M; Laharrague P; Penicaud L; Casteilla L; Blancher A
Br J Haematol; 2005 Apr; 129(1):118-29. PubMed ID: 15801964
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
12. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
13. Histocompatibility testing of cultivated human bone marrow stromal cells - a promising step towards pre-clinical screening for allogeneic stem cell therapy.
Koppula PR; Chelluri LK; Polisetti N; Vemuganti GK
Cell Immunol; 2009; 259(1):61-5. PubMed ID: 19577229
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
16. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction.
Mueller LP; Luetzkendorf J; Mueller T; Reichelt K; Simon H; Schmoll HJ
Stem Cells; 2006 Dec; 24(12):2753-65. PubMed ID: 16931776
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.
Jones EA; English A; Kinsey SE; Straszynski L; Emery P; Ponchel F; McGonagle D
Cytometry B Clin Cytom; 2006 Nov; 70(6):391-9. PubMed ID: 16977637
[TBL] [Abstract][Full Text] [Related]
18. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
[TBL] [Abstract][Full Text] [Related]
19. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
